WuXi PharmaTech Selected as One of the Top Ten Employer for New College Graduates in Pharmaceutical Industry in 2009

SHANGHAI, Aug. 14 /PRNewswire-Asia/ — WuXi PharmaTech (Cayman) Inc. (NYSE:
WX), a leading pharmaceutical, biotechnology, and medical device research and
development outsourcing company, with operations in China and the United
States, today announced that it had been selected as one of the top ten
employers in the pharmaceutical industry in China in an online survey of new
college graduates by China HR, a leading recruitment website in China. WuXi
PharmaTech was the only contract research organization winning this award.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The survey captures the views of 210,000 Chinese students and covers
approximately 630 universities and 3,800 businesses. The winning companies
were selected on the basis of career development opportunities, enterprise
capabilities, culture, and salary and benefits. Now in its sixth year, the
survey has become the authoritative source of the opinions of new college
graduates in China.

“College students in China have enormous potential, and it is essential
that the best Chinese companies tap their talent,” said Bob Zhu, Vice
President of Human Resources and Corporate Communications. “At WuXi
PharmaTech, our people are our most valuable asset and the source of our
innovation. We strive to provide the college graduates that we hire with
fulfilling careers in one of the world’s most dynamic and important
industries-pharmaceutical research and development.”

WuXi PharmaTech has one of the best-educated and best-trained work forces
in China. The company provides extensive training to our more than 4,000
employees, both in specific job skills and in more general areas, such as the
English language and business management. The WuXi PharmaTech Science Seminar
series invites the world’s top scientific minds and leaders in the
pharmaceutical industry to speak to our company’s scientists, thereby
enriching their work experience and enhancing their scientific knowledge.

    For more information, please contact:

    WuXi PharmaTech (Cayman) Inc.
     Ronald Aldridge (for investors)
     Director of Investor Relations
     Tel:   +1-201-585-2048
     Email: ir@wuxiapptec.com

     Stephanie Liu (for the media)
     Tel:   +86-21-5046-4362
     Email: pr@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.